Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1956 1
1958 2
1963 2
1965 2
1967 2
1968 1
1969 4
1970 4
1971 6
1972 2
1973 1
1975 3
1976 5
1977 2
1978 2
1980 1
1981 5
1982 3
1983 2
1984 2
1985 3
1986 3
1987 6
1988 13
1989 14
1990 9
1991 7
1992 8
1993 7
1994 3
1995 15
1996 22
1997 15
1998 20
1999 12
2000 9
2001 12
2002 5
2003 5
2004 6
2005 10
2006 19
2007 16
2008 22
2009 30
2010 32
2011 52
2012 76
2013 75
2014 65
2015 76
2016 81
2017 77
2018 105
2019 108
2020 149
2021 188
2022 162
2023 161
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

1,617 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.
Kristensen LE, Keiserman M, Papp K, McCasland L, White D, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Behrens F. Kristensen LE, et al. Among authors: soliman am. Ann Rheum Dis. 2022 Feb;81(2):225-231. doi: 10.1136/annrheumdis-2021-221019. Epub 2021 Dec 15. Ann Rheum Dis. 2022. PMID: 34911706 Free PMC article. Clinical Trial.
Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis.
Thai NLB, Mai NY, Vuong NL, Tin NM, Karam D, Refaey MA, Shahin KM, Soliman AL, Al Khudari R, Thuan TM, Sabbah GM, El-Qushayri AE, Karimzadeh S, Hirayama K, Huy NT. Thai NLB, et al. Among authors: soliman al. Am J Otolaryngol. 2022 Mar-Apr;43(2):103337. doi: 10.1016/j.amjoto.2021.103337. Epub 2021 Dec 20. Am J Otolaryngol. 2022. PMID: 34973662 Review.
COVID-19 Tracheostomy Outcomes.
Molin N, Myers K, Soliman AMS, Schmalbach CE. Molin N, et al. Among authors: soliman ams. Otolaryngol Head Neck Surg. 2022 Dec;167(6):923-928. doi: 10.1177/01945998221075610. Epub 2022 Feb 1. Otolaryngol Head Neck Surg. 2022. PMID: 35104190 Free PMC article.
Reply.
El Rayes EN, Habib AM, Soliman AH, Ibrahim OM, El Sawwah KMH. El Rayes EN, et al. Among authors: soliman ah. Retina. 2023 Feb 1;43(2):e8-e9. doi: 10.1097/IAE.0000000000003654. Retina. 2023. PMID: 36695806 No abstract available.
Global Cancer Education.
Soliman AS, Chamberlain RM. Soliman AS, et al. J Cancer Educ. 2021 Jul;36(Suppl 1):1-2. doi: 10.1007/s13187-021-02045-8. Epub 2021 Jun 12. J Cancer Educ. 2021. PMID: 34120327 No abstract available.
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Papp KA, et al. Among authors: soliman am. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. Br J Dermatol. 2021. PMID: 34157132 Free PMC article. Clinical Trial.
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Alperovich G, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Kivitz A. Östör A, et al. Among authors: soliman am. Ann Rheum Dis. 2022 Mar;81(3):351-358. doi: 10.1136/annrheumdis-2021-221048. Epub 2021 Nov 23. Ann Rheum Dis. 2022. PMID: 34815219 Free PMC article. Clinical Trial.
1,617 results